НовостиBenzingaKailera Therapeutics Completes Enrollment In KaiNETIC Global Phase 3 Clinical Program; Topline Data Now Expected In Mid-2028 Kailera Therapeutics Completes Enrollment In KaiNETIC Global Phase 3 Clinical Program; Topline Data Now Expected In Mid-2028 Benzinga 2026.09.30 11:04 (GMT+0) Открыть на Benzinga Другие новости